CZIBERE AKOS (Chief Medical Officer) sold 12.50K shares of AKTIS ONCOLOGY, INC. on the open market
Open‑market sale worth $258.6K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 9/24/2026ACC: 0001193125-26-401014
Officer· Chief Medical Officer
Since Jan 2026
-12.50K
Net shares
Net seller
$258.6K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
12.50K acquired · 25K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+12.50K
Price / share
$4.95
Trade value
$61.88K
% of position
New position
9/23/2026
0.00→12.50K
Common Stock
Direct
Shares
−5.10K
Price / share
$20.19
Trade value
$102.97K
% of position
40.8%
9/23/2026
12.50K→7.40K
Common Stock
Direct
Shares
−7.40K
Price / share
$21.03
Trade value
$155.65K
% of position
New position
9/23/2026
7.40K→0.00
Total
Net shares
+0.00
Net value
-$196.75K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/23/2026 | M · Option Exercise | +12.50K | $4.95 | $61.88K | New position | 0.00 | 12.50K |
| Common Stock Direct | 9/23/2026 | S · Sale | −5.10K | $20.19 | $102.97K | 40.8% | 12.50K | 7.40K |
| Common Stock Direct | 9/23/2026 | S · Sale | −7.40K | $21.03 | $155.65K | New position | 7.40K | 0.00 |
| Total | +0.00 | -$196.75K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
12.50K shares
Shares
−12.50K
Strike price
4.95
Held after
208.72K
Exercisable
—
9/23/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock12.50K shares | 9/23/2026 | M · Option Exercise | −12.50K | 4.95 | — | 208.72K |